2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine

C73H74FN31O4 — CID 159293166

IUPAC2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine
SMILESCCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1.COc1ccc(CCCn2ncc3c2nc(N)n2nc(-c4ccco4)nc32)cc1.Cc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)c(F)c1.Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
InChIInChI=1S/C23H24FN9O.C20H19N7O2.C18H15N7O.C12H16N8/c1-15-4-5-18(17(24)13-15)31-9-6-30(7-10-31)8-11-32-21-16(14-26-32)22-27-20(19-3-2-12-34-19)29-33(22)23(25)28-21;1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18;19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14;1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h2-5,12-14H,6-11H2,1H3,(H2,25,28);3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24);1-7,10-11H,8-9H2,(H2,19,22);6-7H,3-5H2,1-2H3,(H2,13,16,17)
InChIKeyLAJOFOJAVZFQGP-UHFFFAOYSA-N
MW1468.61 g/mol
LogP8.97
Rot. Bonds19

About 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine

2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine (PubChem CID 159293166) has the molecular formula C73H74FN31O4 and a molecular weight of 1468.61 g/mol. Its IUPAC name is 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine.

Molecular Properties

Compound Name2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine
PubChem CID159293166
Molecular FormulaC73H74FN31O4
Molecular Weight1468.61 g/mol
Exact Mass1467.65
IUPAC Name2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine
SMILESCCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1.COc1ccc(CCCn2ncc3c2nc(N)n2nc(-c4ccco4)nc32)cc1.Cc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)c(F)c1.Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
InChIInChI=1S/C23H24FN9O.C20H19N7O2.C18H15N7O.C12H16N8/c1-15-4-5-18(17(24)13-15)31-9-6-30(7-10-31)8-11-32-21-16(14-26-32)22-27-20(19-3-2-12-34-19)29-33(22)23(25)28-21;1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18;19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14;1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h2-5,12-14H,6-11H2,1H3,(H2,25,28);3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24);1-7,10-11H,8-9H2,(H2,19,22);6-7H,3-5H2,1-2H3,(H2,13,16,17)
InChIKeyLAJOFOJAVZFQGP-UHFFFAOYSA-N
XLogP8.97
TPSA416.22 Ų
H-Bond Donors4
H-Bond Acceptors35
Rotatable Bonds19
Heavy Atoms109
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001468.61
LogP ≤ 58.97
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1035

Analyze 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine?
The IUPAC name of 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine (CID 159293166) is 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine.
What is the SMILES notation for 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine?
The canonical SMILES for 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine is CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1.COc1ccc(CCCn2ncc3c2nc(N)n2nc(-c4ccco4)nc32)cc1.Cc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)c(F)c1.Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12.
What is the InChIKey of 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine?
The InChIKey is LAJOFOJAVZFQGP-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24FN9O.C20H19N7O2.C18H15N7O.C12H16N8/c1-15-4-5-18(17(24)13-15)31-9-6-30(7-10-31)8-11-32-21-16(14-26-32)22-27-20(19-3-2-12-34-19)29-33(22)23(25)28-21;1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18;19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14;1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h2-5,12-14H,6-11H2,1H3,(H2,25,28);3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24);1-7,10-11H,8-9H2,(H2,19,22);6-7H,3-5H2,1-2H3,(H2,13,16,17).
What are the key properties of 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine?
2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine has a molecular weight of 1468.61 g/mol, XLogP of 8.97, 19 rotatable bonds, 4 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine;10-[2-[4-(2-fluoro-4-methylphenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine;4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine is sourced from PubChem (CID 159293166), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).